PLRX — Pliant Therapeutics Share News
0.000.00%
Last trade - 00:00- $50.52m
- -$107.59m
U.S. STOCKS ON THE MOVE-Hess Corp, Monro, MarketAxess
U.S. STOCKS ON THE MOVE-Block Inc, Fennec, Inhibikase Therapeutics
Pliant Therapeutics ticks higher after upsized $250 mln stock offering
Brief: Pliant Therapeutics Announces Pricing Of Upsized $250 Mln Public Offering
U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics
Pliant Therapeutics rises after brokerages boost PT
Brief: Pliant Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Pliant Therapeutics, Skechers USA, Inspira Tech
Pliant Therapeutics jumps on positive data from lung disease drug trial
U.S. STOCKS ON THE MOVE-Pliant Therapeutics , Wayfair, Evoqua Water Technologies
U.S. STOCKS ON THE MOVE-BiondVax Pharma, Evoqua Water, Wayfair
U.S. STOCKS ON THE MOVE-Salesforce, Western Digital, Pliant Therapeutics
Pliant Therapeutics jumps on positive data from lung disease drug trial
U.S. RESEARCH ROUNDUP-Apollo Endosurgery, Comerica, State Street Corp
Brief: Pliant Therapeutics Announces Positive Data From The INTEGRIS-IPF Phase 2a Trial
Brief: Pliant Therapeutics Gets Orphan Designation From European Medicines Agency For PLN-74809
Brief: Pliant Therapeutics Inc Reports Q3 Revenue Of $1.5 Million
Pliant Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Pliant Therapeutics Inc expected to post a loss of 74 cents a share - Earnings Preview